Menu

Investors

Immediate Reports

Date

Description

Download

16/01/2020

Discovery and patent for Can-Fite and Univo: Cannabis-based formulations for the treatment of a range of illnesses

Hebrew PDF
English PDF

14/01/2020

UNV entered into a binding agreement with SuperPharm for the sale of more than 1.7 tons of medical cannabis in 2020

Hebrew PDF

01/01/2020

Permanent GMP-IMC certification awarded for medical cannabis product R&D laboratory

Hebrew PDF

25/12/2019

Subsidiary UNV has entered into an agreement for the sale of medical cannabis products to another two pharmacies

Hebrew PDF

19/12/2019

Approval received from the Ministry of Health to carry out R&D on cannabis-based medical formulations

Hebrew PDF

17/12/2019

Mor Investments to invest NIS 3 million in Univo in consideration for a (non-negotiable) right to receive 1.25 million shares; amount may rise to NIS 5.25 million

Hebrew PDF

12/12/2019

Binding agreement for the sale of medical cannabis in a quantity of 250 kg to 2 tons to the Medi-Plus pharmacy chain

Hebrew PDF

01/12/2019

Sales to medical cannabis patients commenced, revenues expected in Q4, intention to expand the distribution system

Hebrew PDF

25/11/2019

Receipt of a license for distribution and transportation of medical cannabis products.

Hebrew PDF

24/11/2019

Agreement for the manufacture of medical cannabis-based products for Teva Adir

Hebrew PDF
1 2 3 4 5 6 7 8 9

UNIVO

About Univo

Management

Directors

R&D

Contact Us

Products

All Products

CBD-Dominant

THC-Dominant

THC&CBD Balanced

Investors

Investors Lobby

Financials

Immediate Reports

Presentations

Annual Meetings

Copyright © 2019 UNV Medicine LTD. All rights reserved. This information—including product information—is intended only for residents of  Israel. The products discussed herein may have different labeling in different countries.